長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4536】参天製薬

【4536】参天製薬
製薬。眼科。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 協和キリン ロート製薬


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/07 Q2予 302,000 → 0.0% +1.7% 44,500 → 0.0% 0.0% 45,000 → 0.0% 0.0% 32,500 - - -
2025.03 2024/08/06 Q1予 302,000 ↑ +1.7% +1.7% 44,500 → 0.0% 0.0% 45,000 → 0.0% 0.0% - - - -
2025.03 2024/05/09 当初予 297,000 - - - 44,500 - - - 45,000 - - - - - - -
2024.03 2024/05/09 実 301,965 ↓ -0.0% +10.6% 38,541 ↓ -6.0% +20.4% 29,874 ↓ -22.0% +0.2% 26,642 - - -
2024.03 2024/02/08 Q3予 302,000 → 0.0% +10.6% 41,000 → 0.0% +28.1% 38,300 → 0.0% +28.5% - - - -
2024.03 2023/11/07 Q2予 302,000 ↑ +6.0% +10.6% 41,000 ↑ +17.1% +28.1% 38,300 ↑ +16.4% +28.5% - - - -
2024.03 2023/09/20 修正予 285,000 ↑ +4.4% +4.4% 35,000 ↑ +9.4% +9.4% 32,900 ↑ +10.4% +10.4% - - - -
2024.03 2023/08/03 Q1予 273,000 → 0.0% 0.0% 32,000 → 0.0% 0.0% 29,800 → 0.0% 0.0% - - - -
2024.03 2023/05/11 当初予 273,000 - - - 32,000 - - - 29,800 - - - - - - -
2023.03 2023/05/11 実 279,037 ↑ +0.0% +5.7% -3,090 ↑ +0.3% -109.0% -5,799 ↑ +0.0% -117.8% -14,948 - - -
2023.03 2023/04/27 修正予 279,000 ↑ +2.6% +5.7% -3,100 ↑ +52.3% -109.1% -5,800 ↑ +31.8% -117.8% - - - -
2023.03 2023/02/07 Q3予 272,000 ↓ -2.9% +3.0% -6,500 ↓ -262.5% -119.0% -8,500 ↓ -383.3% -126.2% - - - -
2023.03 2022/11/08 Q2予 280,000 ↑ +6.1% +6.1% 4,000 ↓ -88.3% -88.3% 3,000 ↓ -90.8% -90.8% - - - -
2023.03 2022/08/04 Q1予 264,000 → 0.0% 0.0% 34,200 → 0.0% 0.0% 32,500 → 0.0% 0.0% - - - -
2023.03 2022/05/10 当初予 264,000 - - - 34,200 - - - 32,500 - - - - - - -
2022.03 2022/05/10 実 266,257 ↑ +2.4% +2.4% 35,886 ↓ -13.5% -13.5% 35,616 ↓ -13.1% -13.1% 27,218 - - -
2022.03 2022/02/10 Q3予 260,000 → 0.0% 0.0% 41,500 → 0.0% 0.0% 41,000 → 0.0% 0.0% - - - -
2022.03 2021/11/08 Q2予 260,000 → 0.0% 0.0% 41,500 → 0.0% 0.0% 41,000 → 0.0% 0.0% - - - -
2022.03 2021/08/06 Q1予 260,000 → 0.0% 0.0% 41,500 → 0.0% 0.0% 41,000 → 0.0% 0.0% - - - -
2022.03 2021/05/11 当初予 260,000 - - - 41,500 - - - 41,000 - - - - - - -
2021.03 2021/05/11 実 249,605 ↑ +0.2% +6.2% 12,917 ↓ -10.9% -63.1% 12,418 ↓ -11.3% -63.5% 6,830 - - -
2021.03 2021/04/09 修正予 249,000 ↑ +6.0% +6.0% 14,500 ↓ -58.6% -58.6% 14,000 ↓ -58.8% -58.8% - - - -
2021.03 2021/02/04 Q3予 235,000 → 0.0% 0.0% 35,000 → 0.0% 0.0% 34,000 → 0.0% 0.0% - - - -
2021.03 2020/11/06 Q2予 235,000 → 0.0% 0.0% 35,000 → 0.0% 0.0% 34,000 → 0.0% 0.0% - - - -
2021.03 2020/08/05 Q1予 235,000 → 0.0% 0.0% 35,000 → 0.0% 0.0% 34,000 → 0.0% 0.0% - - - -
2021.03 2020/05/08 当初予 235,000 - - - 35,000 - - - 34,000 - - - - - - -
2020.03 2020/05/08 実 241,555 ↓ -2.6% -2.6% 33,535 ↓ -2.8% -2.8% 32,091 ↓ -6.4% -6.4% 23,618 - - -
2020.03 2020/02/04 Q3予 248,000 → 0.0% 0.0% 34,500 → 0.0% 0.0% 34,300 → 0.0% 0.0% - - - -
2020.03 2019/11/06 Q2予 248,000 → 0.0% 0.0% 34,500 → 0.0% 0.0% 34,300 → 0.0% 0.0% - - - -
2020.03 2019/08/01 Q1予 248,000 → 0.0% 0.0% 34,500 → 0.0% 0.0% 34,300 → 0.0% 0.0% - - - -
2020.03 2019/05/09 当初予 248,000 - - - 34,500 - - - 34,300 - - - - - - -
2019.03 2019/05/09 実 234,026 ↓ -1.3% -1.3% 45,098 ↑ +10.8% +10.8% 43,117 ↑ +4.4% +4.4% 31,954 - - -
2019.03 2019/02/05 Q3予 237,000 → 0.0% 0.0% 40,700 → 0.0% 0.0% 41,300 → 0.0% 0.0% - - - -
2019.03 2018/11/07 Q2予 237,000 → 0.0% 0.0% 40,700 → 0.0% 0.0% 41,300 → 0.0% 0.0% - - - -
2019.03 2018/08/01 Q1予 237,000 → 0.0% 0.0% 40,700 → 0.0% 0.0% 41,300 → 0.0% 0.0% - - - -
2019.03 2018/05/09 当初予 237,000 - - - 40,700 - - - 41,300 - - - - - - -
2018.03 2018/05/09 実 224,942 ↑ +0.4% +3.2% 38,691 ↑ +3.5% +3.5% 39,261 ↑ +4.1% +4.1% 35,247 ↑ +9.8% +31.0%
2018.03 2018/02/06 Q3予 224,000 ↑ +2.8% +2.8% 37,400 → 0.0% 0.0% 37,700 → 0.0% 0.0% 32,100 ↑ +19.3% +19.3%
2018.03 2017/11/01 Q2予 218,000 → 0.0% 0.0% 37,400 → 0.0% 0.0% 37,700 → 0.0% 0.0% 26,900 → 0.0% 0.0%
2018.03 2017/08/01 Q1予 218,000 → 0.0% 0.0% 37,400 → 0.0% 0.0% 37,700 → 0.0% 0.0% 26,900 → 0.0% 0.0%
2018.03 2017/05/10 当初予 218,000 - - - 37,400 - - - 37,700 - - - 26,900 - - -
2017.03 2017/05/10 実 199,096 ↓ -0.5% -0.5% 32,479 ↓ -10.5% -10.5% 31,822 ↓ -12.8% -12.8% 23,061 ↓ -8.8% -8.8%
2017.03 2017/02/07 Q3予 200,000 → 0.0% 0.0% 36,300 → 0.0% 0.0% 36,500 → 0.0% 0.0% 25,300 → 0.0% 0.0%
2017.03 2016/08/02 当初予 200,000 - - - 36,300 - - - 36,500 - - - 25,300 - - -
2016.03 2016/05/11 実 - - - - - - - - - - - - - - - -
2016.03 2016/02/02 Q3予 197,500 ↑ +5.9% +5.9% 80,000 ↑ +2.6% +2.6% 80,500 ↑ +2.5% +2.5% 53,000 ↑ +1.0% +1.0%
2016.03 2015/11/04 Q2予 186,500 → 0.0% 0.0% 78,000 → 0.0% 0.0% 78,500 → 0.0% 0.0% 52,500 → 0.0% 0.0%
2016.03 2015/08/04 Q1予 186,500 → 0.0% 0.0% 78,000 → 0.0% 0.0% 78,500 → 0.0% 0.0% 52,500 → 0.0% 0.0%
2016.03 2015/05/12 当初予 186,500 - - - 78,000 - - - 78,500 - - - 52,500 - - -
2015.03 2015/05/12 実 161,831 ↑ +3.7% +7.2% 35,374 ↑ +17.9% +26.3% 35,863 ↑ +19.5% +25.8% 24,032 ↑ +23.2% +29.2%
2015.03 2015/02/03 Q3予 156,000 → 0.0% +3.3% 30,000 → 0.0% +7.1% 30,000 → 0.0% +5.3% 19,500 → 0.0% +4.8%
2015.03 2014/11/05 Q2予 156,000 → 0.0% +3.3% 30,000 → 0.0% +7.1% 30,000 → 0.0% +5.3% 19,500 → 0.0% +4.8%
2015.03 2014/08/05 Q1予 156,000 ↑ +3.3% +3.3% 30,000 ↑ +7.1% +7.1% 30,000 ↑ +5.3% +5.3% 19,500 ↑ +4.8% +4.8%
2015.03 2014/05/13 当初予 151,000 - - - 28,000 - - - 28,500 - - - 18,600 - - -
2014.03 2014/05/13 実 148,663 - - - 27,414 - - - 27,924 - - - 17,109 - - -
シェア ツイート
ページトップへ戻る